Evidence map›Paper›PMID 39166636›Full record

ArticleRevista peruana de medicina experimental y salud publica2024

Detection of SARS-CoV-2 variants in hospital wastewater in Peru, 2022.

Pool Marcos-Carbajal, José Yareta-Yareta, Miguel Otiniano-Trujillo, Marco Galarza-Pérez, Abraham Espinoza-Culupu, Jorge L Ramirez-Melgar, Mario Chambi-Quispe, Néstor Alejandro Luque-Chipana, Rosmery Gutiérrez Ajalcriña, Victor Sucñer Cruz and 8 more

Abstract read
In one paragraph

Article in Revista peruana de medicina experimental y salud publica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Pool Marcos-CarbajalUniversidad Peruana Unión, Escuela Profesional Medicina, Laboratorio de Investigación en Biología Molecular. Lima, Perú.ORCID http://orcid.org/0000-0002-7741-0337
José Yareta-YaretaUniversidad Peruana Unión, Escuela Profesional Medicina, Laboratorio de Investigación en Biología Molecular. Lima, Perú.ORCID http://orcid.org/0000-0002-8909-1724
Miguel Otiniano-TrujilloUniversidad Peruana Unión, Escuela Profesional Medicina, Laboratorio de Investigación en Biología Molecular. Lima, Perú.ORCID http://orcid.org/0000-0002-8989-6637
Marco Galarza-PérezInstituto Nacional de Salud, Centro Nacional de Salud Pública, Laboratorio de Biotecnología y Biología molecular. Lima, Perú.ORCID http://orcid.org/0000-0002-6547-2354
Abraham Espinoza-CulupuUniversidad Nacional Mayor de San Marcos, Facultad de Ciencias Biológicas. Lima, Perú.ORCID http://orcid.org/0000-0002-5553-6385
Jorge L Ramirez-MelgarUniversidad Nacional Mayor de San Marcos, Facultad de Ciencias Biológicas. Lima, Perú.ORCID http://orcid.org/0000-0001-8138-9203
Mario Chambi-QuispeHospital Carlos Monge Medrano, Patología Clínica. Puno, Perú.ORCID http://orcid.org/0000-0003-3303-2087
Néstor Alejandro Luque-ChipanaUniversidad Peruana Unión, Escuela Profesional Medicina, Laboratorio de Investigación en Biología Molecular. Lima, Perú.ORCID http://orcid.org/0000-0002-6192-4392
Rosmery Gutiérrez AjalcriñaHospital de Huaycan, Área de Epidemiología. Lima, Perú.ORCID http://orcid.org/0000-0001-8237-6092
Victor Sucñer CruzHospital Regional del Cusco, Patología Clínica. Cusco, Perú.ORCID http://orcid.org/0009-0009-5302-8502
Segundo Nicolas López ChegneHospital Regional de Cajamarca, Patología Clínica. Cajamarca, Perú.ORCID http://orcid.org/0000-0001-6480-1235
Diana Santillán RuizHospital de Tarapoto, Departamento de Anatomía Patológica y Patología Clínica. Tarapoto, Perú.ORCID http://orcid.org/0009-0009-8982-9539
Luis Felipe Segura ChavezUniversidad Peruana Unión, Escuela Profesional Medicina, Laboratorio de Investigación en Biología Molecular. Lima, Perú.ORCID http://orcid.org/0000-0002-1665-4733
Cinthia Esther Sias GarayUniversidad Peruana Unión, Escuela Profesional Medicina, Laboratorio de Investigación en Biología Molecular. Lima, Perú.ORCID http://orcid.org/0009-0006-1099-1620
Alberto Salazar GranaraUniversidad San Martin de Porres, Centro de Investigación en Medicina Tradicional y Farmacología. Lima, Perú.ORCID http://orcid.org/0000-0003-1996-3176
Pablo Tsukayama CisnerosUniversidad Peruana Cayetano Heredia, Laboratorio de Genómica Microbiana. Lima, Perú.ORCID http://orcid.org/0000-0002-1669-2553
Silvana Teresa Tapia PaniaguaUniversidad de Málaga, Departamento de Microbiología, Facultad de Ciencias. Málaga, España.ORCID http://orcid.org/0000-0002-3656-5009
Carmen María González-DomenechUniversidad de Málaga, Departamento de Microbiología, Facultad de Ciencias. Málaga, España.ORCID http://orcid.org/0000-0001-8248-3904

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

OBJECTIVE.: To identify the presence of the SARS-CoV-2 virus in wastewater from hospitals in Peru. MATERIALS AND METHODS.: Water samples were collected from the effluents of nine hospitals in Peru during March and September 2022. SARS-CoV-2 was identified by using Illumina sequencing. Variant, lineage and clade assignments were carried out using the Illumina and Nextclado tools. We verified whether the SARS-CoV-2 variants obtained from wastewater were similar to those reported by the National Institute of Health of Peru from patients during the same period and region. RESULTS.: Eighteen of the 20 hospital wastewater samples (90%) provided sequences of sufficient quality to be classified as the Omicron variant according to the WHO classification. Among them, six (30%) were assigned by Nextclade to clades 21K lineage BA.1.1 (n=1), 21L lineage BA.2 (n=2), and 22B lineages BA.5.1 (n=2) and BA .5.5 (n=1). CONCLUSIONS.: SARS-CoV-2 variants were found in hospital wastewater samples and were similar to those reported by the surveillance system in patients during the same weeks and geographic areas. Wastewater monitoring could provide information on the environmental and temporal variation of viruses such as SARS-CoV-2. Motivation for the study. To contribute to the surveillance of environmental samples from hospital effluents in order to achieve early warning of possible infectious disease outbreaks. Main findings. The Omicron variant of the COVID-19 virus was detected in wastewater from hospitals in Puno, Cuzco and Cajamarca; these results are similar to the reports by the Peruvian National Institute of Health based on nasopharyngeal swab samples. Implications. The presence of the Omicron variant in hospital wastewater during the third wave of the pandemic should raise awareness of the treatment system before wastewater is discharged into the public sewer system.

Indexed as

HospitalsSARS-CoV-2WastewaterCOVID-19HumansPeruWastewater

Identifiers

PMID39166636
PMCPMC11300693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.